Resmed (RMD) Net Cash Flow (2009 - 2026)

Resmed (RMD) has 18 years of Net Cash Flow data on file, last reported at $240.9 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 40.2% year-over-year to $240.9 million; the trailing twelve-month figure through Mar 2026 stood at $687.0 million (down 2.48% YoY), and the FY2025 full-year result was $945.3 million, up 7655.27% from the prior year.
• Net Cash Flow for Q1 2026 stood at $240.9 million, up from $30.5 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $402.8 million in Q1 2025 and bottomed at -$56.0 million in Q3 2022.
• The 5-year median for Net Cash Flow is $33.0 million (2024), against an average of $85.2 million.
• The widest annual swing landed in 2023, when Net Cash Flow plunged 454.16%; it then surged 74796.27% in 2025.
• A 5-year view of Net Cash Flow shows it stood at $35.1 million in 2022, then sank by 120.69% to -$7.3 million in 2023, then surged by 1811.28% to $124.4 million in 2024, then tumbled by 75.52% to $30.5 million in 2025, then jumped by 690.9% to $240.9 million in 2026.
• The last three Net Cash Flow figures came in at $240.9 million (Q1 2026), $30.5 million (Q4 2025), and $174.5 million (Q3 2025), per Business Quant data.

Peer Comparison